IOVANCE BIOTHERAPEUTICS FACILITY GROUNDBREAKING AT THE NAVY YARD

Iovance Biotherapeutics, Inc., a late-stage biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, hosted a groundbreaking ceremony to build an approximately 136,000 square foot commercial-scale production facility at the Navy Yard. Check out our photo gallery covering the June event. Read more about the facility and the amazing work of Iovance Biotherapeutics, Inc. here on the Navy Yard Blog.